WNT5A and breast carcinoma: In subsequent animal experiments with WNT5A-negative 4T1 breast cancer cells inoculated orthotopically in mammary fat pads, we were able to show that treatment every 4th day with Foxy5 for up to 24 days significantly reduced the metastatic spread by 70–80% [56].